Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
about
Gentamicin pharmacokinetics in the chicken inner earEvaluation of hearing impairment.Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits.Correlation of aminoglycoside dosages with serum concentrations during therapy of serious gram-negative bacillary diseaseGentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex.Aspects on the ototoxic potential of netilmicin.Drug-induced ototoxicity. Pathogenesis and prevention.Netilmicin: a review of toxicity in laboratory animals.Correlation of amikacin concentrations in perilymph and plasma of continuously infused guinea pigs.Effect of pentobarbital anesthesia on amikacin concentrations in plasma and perilymph and evaluation of multiple sampling in perilymph of guinea pigsModification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.Brainstem auditory evoked responses in 37 dogs with otitis media before and after topical therapy.Evidence that amikacin ototoxicity is related to total perilymph area under the concentration-time curve regardless of concentration.Once-daily administration of aminoglycosides.Clinical pharmacology of tobramycin in infants.Comparative pharmacokinetics of aminoglycoside antibiotics in guinea pigs[Ototoxicity of the aminoglycoside antibiotics (author's transl)].Comparative cochlear toxicities of streptomycin, gentamicin, amikacin and netilmicin in guinea-pigs.Vestibulotoxicity with systemic gentamicin in different dosing regimens: Our experience in 46 patients.Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides.Gentamicin distribution from a collagen carrier.Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph.Delay in Hearing Loss Following Drug Administration
P2860
Q30492662-82C1C1DE-70BB-4E20-B839-A4E55BDC54B4Q34477103-33AF03EB-F9EE-4D1B-AC41-D919B37BD9BAQ35649088-51535553-9AF6-4CE1-81BC-89EFC1DD156BQ36467335-54C5D383-02D8-42FD-91CF-9445DC7F73EEQ36483889-02E3E026-1E1B-4308-9FED-8DBA307211C3Q36573085-29944346-D25B-4A87-AC72-D6782FCBF61AQ36616913-DDD9EA53-B16C-4669-96CA-BA3AC0C5B540Q38742605-BC1D424D-28DD-43D7-A8C2-DF9AA778AD92Q39771096-3FCA68B3-5DF2-4C27-AE99-186F1C752180Q39848947-000C3B47-5808-4317-9A13-D7246F357929Q39849843-82171E0E-0DBE-4825-A1DF-D53C4B7F7603Q40022701-8AD3E566-53AB-42DF-983F-15F87C13263CQ40130461-86E56F12-9615-49C2-9266-452AC7398DC0Q40284216-4444DB7F-1645-4905-92E1-DB5D62D0BD5FQ40627605-AAE9B9F5-E04C-4424-9A27-ADFB76164BA8Q41429787-CC91E2E0-B0FE-4A06-9A1F-B299AA922B54Q42146724-86C674C1-4183-474F-9C94-4B7C167E4C54Q44076254-BBC27955-019D-4030-8F7E-27A51A08BA07Q44139574-0404A34E-D5A3-42B0-915E-9D88D30F8CDCQ44183930-5B9A7E24-5CD4-4F6C-A860-650683DF8179Q45006893-14D2A2A4-7CFD-4CC1-B1AE-1C54B99C3CD4Q50194148-6B236835-29C4-44AC-A1CE-A341D77C982AQ53888258-ECBD2CFB-3137-481E-95CC-E7A89D14793EQ58176539-B967EC06-F633-4E70-BCE4-0C8258B5EC7B
P2860
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
@en
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
@nl
type
label
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
@en
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
@nl
prefLabel
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
@en
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
@nl
P2093
P1476
Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
@en
P2093
Federspil P
Schätzle W
P304
P356
10.1093/INFDIS/134.SUPPLEMENT_1.S200
P407
P478
P577
1976-08-01T00:00:00Z